Fibrin
- Generic Name
- Fibrin
- Drug Type
- Biotech
- CAS Number
- 9001-31-4
- Unique Ingredient Identifier
- AQ4K8I4R6F
Post-Operative Drainage Following Lymph Node Dissection
- Conditions
- Malignant MelanomaCarcinoma, Squamous Cell
- Interventions
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Oxford University Hospitals NHS Trust
- Target Recruit Count
- 74
- Registration Number
- NCT00324272
Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
- Conditions
- Blood Loss, Surgical
- Interventions
- Device: Oxidized Regenerated Cellulose (Surgicel)
- First Posted Date
- 2006-03-28
- Last Posted Date
- 2009-01-09
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT00307515
- Locations
- 🇺🇸
St. Agnes Healthcare, Inc., Baltimore, Maryland, United States
🇺🇸Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸Medical College of Georgia, Augusta, Georgia, United States
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
- Conditions
- Cardiac Surgery Requiring Cardiopulmonary Bypass and Median SternotomyCardiopulmonary BypassSternotomy
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT00161733
- Locations
- 🇺🇸
Brevard Cardio Surgeons/Health First Heart Institute, Melbourne, Florida, United States
🇺🇸Peachtree Cardiovascular, Atlanta, Georgia, United States
🇺🇸St. Joseph's/Candler Health System, Inc., Savannah, Georgia, United States
Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites
- Conditions
- Breast CancerLumpectomyMastectomy Plus Axillary Lymph Node DissectionLymphatic Leakage
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-10-23
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT00161980
- Locations
- 🇫🇷
Centre Régional de Lutte Contre le Cancer, Centre Eugène Marquis, Rennes, France
🇮🇹S. Luigi - S. Curro, Presidi Ospedalieri Unificati, Catania, Italy
🇩🇪Ludwig-Maximilians-Universität, Munich, Germany
Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement
- Conditions
- Hip Replacement Surgery
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-10-23
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT00161902
- Locations
- 🇳🇱
Academisch Ziekenhuis Maastricht, Orthopedic Surgery, Maastricht, Netherlands
🇳🇱St. Anna Ziekenhuis, Orthopedic Surgery, Geldrop, Netherlands
🇳🇱St. Clara Ziekenhuis, Orthopedic Surgery, Rotterdam, Netherlands
Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices
- Conditions
- Esophageal and/or Gastric Varices
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-10-23
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT00161915
- Locations
- 🇩🇪
Krankenhaus Zehlendorf, Berlin, Germany
🇩🇪St. Elisabeth Krankenhaus, Wittlich, Germany
🇩🇪Krankenhaus Lichtenberg, Berlin, Germany
Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
- Conditions
- Peripheral Vascular Disease
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2006-07-13
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00154141
- Locations
- 🇺🇸
Univ of Mass Medical Center, Worcester, Massachusetts, United States
🇺🇸Hackensack Medical Center, Hackensack, New Jersey, United States
🇺🇸Alband Medical Center, Albany, New York, United States
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
- Conditions
- LymphedemaPerioperative/Postoperative ComplicationsVulvar Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00028951
- Locations
- 🇺🇸
CCOP - Central Illinois, Decatur, Illinois, United States
🇺🇸Saint Joseph Regional Medical Center, South Bend, Indiana, United States
🇺🇸CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.